View all CPC CME

Share a PER® activity with your colleagues or friends. Connect with the PER® social network.



Accreditation/ Credit Designation

Physicians' Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians' Education Resource®, LLC, designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669 for 2.0 Contact Hours.

Resources

PER Pulse™ Recaps
for the Nursing Opportunities to Improve Outcomes in the Application of Immuno-Oncology Strategies: A Practical Approach to Care symposium focus on the expanding array of immune checkpoint inhibitors for patients with cancer and general differences in toxicity and response kinetics compared with standard therapies.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from AstraZeneca.


Community Practice Connections™: Nursing Opportunities to Improve Outcomes in the Application of Immuno-Oncology Strategies: A Practical Approach to Care


Release Date: June 23, 2016
Expiration Date: June 23, 2017
Media: Internet - based

Activity Overview

This educational activity is geared toward practical applications of treatment strategies in the clinic. Key data related to a live symposium held at a recent oncology nursing meeting, that focused on the use of immuno-oncology strategies, are now available as downloadable slides. Participants can test their knowledge through interactive clinical vignettes and view short video clips from the faculty to understand expert perspectives on clinical scenarios that are faced in the care of patients when using these novel approaches to treat cancer.

CME/CE Activity Table of Contents

  • Immune Checkpoint Inhibitors in Non-Small-Cell Lung Cancer
  • Immune Checkpoint Inhibitors in Melanoma

Instructions For This Activity & Receiving Credit

  • You will need to login to participate in the activity.
  • Each presentation may contain an interactive question(s). You may move forward through the presentation; however, you may not go back to change answers or review videos/content until you finish the presentation.
  • At the end of the activity, "educational content/video" will be available for your reference.
  • In order to receive a CME/CE certificate, participants must complete the activity.
  • Complete the posttest and pass with a score of 70% or higher, complete the evaluation and then click on request for credit. Participants may immediately download a CME/CE certificate upon completion of these steps.


Target Audience

This educational program is directed toward nurses and other health care professionals with an interest in the treatment of cancers with immuno-oncology agents.

Educational Objectives

At the conclusion of this activity, you should be better prepared to:
  • Discuss the underlying mechanisms by which immuno-oncology strategies exert their action in the treatment of cancer and how to discuss these concepts with patients
  • Describe pivotal data and highly anticipated ongoing clinical trials that are evaluating immuno-oncology approaches for the treatment of solid tumors to effectively respond to patient questions concerning these novel approaches
  • Explain important counseling points concerning predictable adverse events associated with immuno-oncology treatments, methods to proactively mitigate their impact, and the importance of clinical trial enrollment
  • Apply a practical knowledge of immuno-oncology strategies to real-world clinical scenarios in which nurses counsel patients with solid tumors

Faculty, Staff, and Planners' Disclosures

Program Co-Chairs

Patrick Forde, MD
Assistant Professor of Oncology
Johns Hopkins University
Baltimore, MD
Disclosure: Grant/Research Support: Bristol-Meyers Squibb, AstraZeneca, Novartis, Kyowa; Consultant: Celgene. 

Joanne Riemer, RN
Johns Hopkins University
Baltimore, MD
Disclosure: No relevant financial relationships with commercial interests.
 
 

Faculty

Jason Luke, MD, FACP
Assistant Professor of Medicine
The University of Chicago Medicine
Chicago, IL
Disclosure: Consultant: Amgen, Array; Clinical Trial Support to Institution: Novartis, MedImmune, Bristol-Meyers Squibb, Pharmacyclics, Merck, BBI Therapeutics, Five Prime Therapeutics, Genentech, Corvus, Abbvie, Celldex, EMD Serono.

Karen Matijevich, RN
The University of Chicago Medicine
Chicago, IL
Disclosure: No relevant financial relationships with commercial interests.
 
 

The staff of Physicians' Education Resource®, LLC, have no relevant financial relationships with commercial interests.

Disclosure Policy and Resolution of Conflicts of Interest (COI)

It is the policy of Physicians' Education Resource®, LLC, (PER®) to ensure fair balance, independence, objectivity, and scientific rigor in all of our CME/CE activities. In accordance with ACCME guidelines, PER® requires everyone who is in a position to control the content of an educational activity, including spouses/partners, to disclose all relevant financial relationships with any commercial interest to participants as a part of the activity planning process. PER® has implemented mechanisms to identify and resolve all conflicts of interest prior to release of this activity.

Off-Label Disclosure and Disclaimer

This CME/CE activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME/CE activity is for continuing medical education purposes only, and is not meant to substitute for the independent medical judgment of a physician or nurse relative to diagnostic, treatment, or management options for a specific patient's medical condition.

The opinions expressed in the content are solely those of the individual faculty members, and do not reflect those of Physicians' Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

Hardware And Software Requirements

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise




Calendar of Events
SUNMONTUESWEDTHURSFRISAT
     12
3456789
10111213141516
17181920212223
24252627282930
Filter By